Literature DB >> 628198

[Myasthenic syndrome during penicillamine treatment (author's transl)].

F Schumm, M Stöhr.   

Abstract

The clinical and electrophysiological findings in 2 men who had developed a myasthenic syndrome after taking penicillamine for rheumatoid arthritis will be described. The symptoms began with dysfunction of the eye muscles following a generalised muscle weakness. Course of illness after withdrawal of penicillamine was not uniform. In one of the patients a complete remission occurred within a year. The other became steadily worse and required continuous treatment with cholinesterase inhibitors. Electrophysiological examinations showed neuromuscular blockade, posttetanic exhaustion, posttetanic potentiation was found in one patient only. An immunopharmacological block of acetylcholine receptors induced by penicillamine is discussed from a pathogenetical point of view.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 628198     DOI: 10.1007/bf01478569

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  29 in total

1.  Penicillamine, a new oral therapy for Wilson's disease.

Authors:  J M WALSHE
Journal:  Am J Med       Date:  1956-10       Impact factor: 4.965

2.  [Penicillamine-induced polymyositis (author's transl)].

Authors:  U Bettendorf; R Neuhaus
Journal:  Dtsch Med Wochenschr       Date:  1974-12-06       Impact factor: 0.628

Review 3.  [10 years of penicillamine].

Authors:  T Werner; H M Weinmann
Journal:  Med Klin       Date:  1966-11-18

4.  Lupus-like syndrome induced by D-penicillamine in Wilson's disease.

Authors:  J P Harpey; B Caille; R Moulias; J M Goust
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

5.  [Acute respiratory dishess syndrome due to high dosage of penicilline in a case of myasthenia gravis (author's transl)].

Authors:  V Draxler
Journal:  Anaesthesist       Date:  1973-11       Impact factor: 1.041

6.  Toxic reactions to penicillamine in patients with Wilson's disease.

Authors:  J M Walshe
Journal:  Postgrad Med J       Date:  1968-10       Impact factor: 2.401

7.  Detection of antibodies in penicillamine sensitivity.

Authors:  H Amos
Journal:  Postgrad Med J       Date:  1968-10       Impact factor: 2.401

Review 8.  [Treatment of rheumatoid arthritis using D-penicillamine].

Authors:  V R Ott; K L Schmidt
Journal:  Internist (Berl)       Date:  1974-06       Impact factor: 0.743

9.  Letter: D-penicillamine and haemolytic anaemia.

Authors:  E E Harrison; J W Hickman
Journal:  Lancet       Date:  1976-01-03       Impact factor: 79.321

10.  [Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)].

Authors:  D Seitz; H C Hopf; R W Janzen; W Meyer
Journal:  Dtsch Med Wochenschr       Date:  1976-07-30       Impact factor: 0.628

View more
  2 in total

1.  Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.

Authors:  W A Scherbaum; F Schumm; B Maisch; C Müller; A Fateh-Moghadam; S H Flüchter; F J Seif; G F Bottazzo; P A Berg
Journal:  Klin Wochenschr       Date:  1983-05-16

2.  [The significance of determining antibodies to acetylcholine receptor in myasthenia gravis (author's transl)].

Authors:  K V Toyka; T Becker; A Fateh-Moghadam; U A Besinger; G Brehm; D Neumeier; K Heininger; K L Birnberger
Journal:  Klin Wochenschr       Date:  1979-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.